FDA 483 - 8046255 Canada Inc. DBA Viatrexx - September 24, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
The FDA inspected 8046255 Canada Inc. DBA Viatrexx, a sterile injectable drug product manufacturer in Beloeil, from September 16-24, 2019. The inspection revealed significant deficiencies in aseptic processing, environmental monitoring, laboratory controls, and quality control record-keeping, indicating a severe lack of adherence to cGMP for sterile drug manufacturing. These issues raise serious concerns about the sterility and quality assurance of their injectable drug products.
ID · 5a6e4438-346a-48c0-9674-280f370ec9c4